Epidemiology of adult rheumatoid arthritis, Autoimmunity Reviews, vol.4, issue.3, pp.130-166, 2005. ,
DOI : 10.1016/j.autrev.2004.09.002
Is rheumatoid arthritis disappearing?, Annals of the Rheumatic Diseases, vol.64, issue.1, pp.7-10, 2005. ,
DOI : 10.1136/ard.2004.023044
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1755215
Comptes nationaux de la santé ? 2011. DREES (Direction de la recherche, des e ´tudes, de l'e ´valuation et des statistiques) Available, 2012. ,
Costs of rheumatoid arthritis in France: a multicenter study of 1109 patients managed by hospital-based rheumatologists, J Rheumatol, vol.31, pp.1297-304, 2004. ,
Disease status, costs and quality of life of patients with rheumatoid arthritis in France: The ECO-PR Study, Joint Bone Spine, vol.75, issue.4, pp.408-423, 2008. ,
DOI : 10.1016/j.jbspin.2007.07.015
The loss of health status in rheumatoid arthritis and the effect of biologic therapy: a longitudinal observational study, Arthritis Research & Therapy, vol.12, issue.2, p.35, 2010. ,
DOI : 10.1186/ar2944
The burden of rheumatoid arthritis and access to treatment: health burden and costs, The European Journal of Health Economics, vol.13, issue.Suppl, pp.49-60, 2008. ,
DOI : 10.1007/s10198-007-0088-8
Economic consequences and potential benefits, Best Practice & Research Clinical Rheumatology, vol.25, issue.4, pp.607-631, 2011. ,
DOI : 10.1016/j.berh.2011.10.001
International Variation in Resource Utilisation and Treatment Costs for Rheumatoid Arthritis, PharmacoEconomics, vol.2, issue.1, pp.243-57, 2005. ,
DOI : 10.2165/00019053-200523030-00005
American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis, Arthritis & Rheumatism, vol.21, issue.2, pp.762-84, 2008. ,
DOI : 10.1002/art.23721
Treatment of Very Early Rheumatoid Arthritis With Symptomatic Therapy, Disease-Modifying Antirheumatic Drugs, or Biologic Agents, Annals of Internal Medicine, vol.151, issue.9, pp.612-633, 2009. ,
DOI : 10.7326/0003-4819-151-9-200911030-00006
Cost Effectiveness Analysis of Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis. A Systematic Review Literature, International Journal of Rheumatology, vol.28, issue.5, supplement 61, pp.10-1155, 2011. ,
DOI : 10.1093/rheumatology/ker084
Cost-ofillness of rheumatoid arthritis and ankylosing spondylitis, Clin Exp Rheumatol, vol.27, pp.118-141, 2009. ,
The ESPOIR cohort: A ten-year follow-up of early arthritis in France, Joint Bone Spine, vol.74, issue.5, pp.440-445, 2007. ,
DOI : 10.1016/j.jbspin.2007.06.001
Démographie et honoraires des médecins libéraux en Caisse nationale de l'Assurance Maladie 23 Available: http://www.ameli.fr/l-assurance-maladie/statistiques-et-publications/points- de-repere/n-23-demographie-honoraires-des-medecins-2006, 2006. ,
The cost of mental disorders in France, European Neuropsychopharmacology, vol.23, issue.8, 2012. ,
DOI : 10.1016/j.euroneuro.2012.08.012
Les distances d'accès aux soins en France métropolitaine au 1er janvier Available: http://www.irdes.fr/ Publications, IRDES, 2007. ,
ENCC MCO 2006: National cost care for medecin surgery obstretics sector (acute care sector), database on the Internet] Available, 2006. ,
Using multilevel models for assessing the variability of multinational resource use and cost data, Health Economics, vol.11, issue.2, pp.185-96, 2005. ,
DOI : 10.1002/hec.916
Hierarchical Linear Models: Applications and Data Analysis Methods. Second Edition, 2001. ,
Measurement of patient outcome in arthritis, Arthritis & Rheumatism, vol.33, issue.2, pp.137-182, 1980. ,
DOI : 10.1002/art.1780230202
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs, Annals of the Rheumatic Diseases, vol.69, issue.6, pp.964-75, 2010. ,
DOI : 10.1136/ard.2009.126532
Imputation of Categorical Variables with PROC MI, Proceedings of the Thirtieth Annual SAS Users Group International (SUGI) Conference, 2005. ,
Missing Data Analysis: Making It Work in the Real World, Annual Review of Psychology, vol.60, issue.1, pp.549-76, 2009. ,
DOI : 10.1146/annurev.psych.58.110405.085530
A comparison of inclusive and restrictive strategies in modern missing data procedures., Psychological Methods, vol.6, issue.4, pp.330-51, 2001. ,
DOI : 10.1037/1082-989X.6.4.330
Multiple Imputation for Nonresponse in Surveys, 1987. ,
DOI : 10.1002/9780470316696
Level of agreement of the 1987 ACR and 2010 ACR/EULAR rheumatoid arthritis classification criteria: an analysis based on ESPOIR cohort data, Annals of the Rheumatic Diseases, vol.71, issue.3, pp.386-89, 2012. ,
DOI : 10.1136/annrheumdis-2011-200259
URL : https://hal.archives-ouvertes.fr/hal-00790235
Drug use and Cost Evaluation In Rheumatoid Arthritis Patients. Value Health16, p.221, 2013. ,
Direct medical expenditure associated with rheumatoid arthritis in a nationally representative sample from the medical expenditure panel survey, Arthritis Care & Research, vol.23, issue.11, pp.1649-56, 2012. ,
DOI : 10.1002/acr.21755
Economic consequences and potential benefits, Best Practice & Research Clinical Rheumatology, vol.25, issue.4, pp.607-631, 2011. ,
DOI : 10.1016/j.berh.2011.10.001
28-joint count disease activity score at 3 months after diagnosis of early rheumatoid arthritis is strongly associated with direct and indirect costs over the following 4 years: the Swedish TIRA project, Rheumatology, vol.50, issue.7, pp.1259-67, 2011. ,
DOI : 10.1093/rheumatology/keq444
Direct medical costs and their predictors in patients with rheumatoid arthritis, Arthritis & Rheumatism, vol.38, issue.Suppl 9, pp.2750-62, 2003. ,
DOI : 10.1002/art.11439
Societal costs of rheumatoid arthritis in Hong Kong: a prevalence-based cost-of-illness study, Rheumatology, vol.50, issue.7, pp.1293-1301, 2011. ,
DOI : 10.1093/rheumatology/ker014
EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT), Annals of the Rheumatic Diseases, vol.66, issue.1, pp.34-45, 2007. ,
DOI : 10.1136/ard.2005.044354
Current evidence for a strategic approach to the management of rheumatoid arthritis with disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis, Annals of the Rheumatic Diseases, vol.69, issue.6, pp.987-994, 2010. ,
DOI : 10.1136/ard.2009.126748
Telescoping is not time compression: A model, Memory & Cognition, vol.2, issue.No. 291, pp.653-61, 1989. ,
DOI : 10.3758/BF03202626
Missing data: Our view of the state of the art., Psychological Methods, vol.7, issue.2, pp.147-77, 2002. ,
DOI : 10.1037/1082-989X.7.2.147
Should a Normal Imputation Model be Modified to Impute Skewed Variables?, Sociological Methods & Research, vol.39, issue.1, pp.105-143, 2013. ,
DOI : 10.1037/1082-989X.7.2.147
Cost-Effectiveness of Biologics in Early Rheumatoid Arthritis, Annals of Internal Medicine, vol.152, issue.5, pp.333-337, 2010. ,
DOI : 10.7326/0003-4819-152-5-201003020-00018